PRN — Profound Medical Balance Sheet
0.000.00%
- CA$229.83m
- CA$187.23m
- $10.68m
Annual balance sheet for Profound Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 83.9 | 67.2 | 46.5 | 26.2 | 54.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.43 | 1.41 | 6.34 | 7.29 | 7.04 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 97.7 | 77.1 | 62 | 41.9 | 69.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.28 | 1.9 | 1.72 | 1.57 | 0.821 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 105 | 86.8 | 64.4 | 44 | 70.2 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.81 | 4.16 | 4.18 | 6.37 | 6.57 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.25 | 6.16 | 12.4 | 12.7 | 9.81 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 97.3 | 80.6 | 52 | 31.2 | 60.4 |
| Total Liabilities & Shareholders' Equity | 105 | 86.8 | 64.4 | 44 | 70.2 |
| Total Common Shares Outstanding |